Hannover Re H1 Net Income Rises 7% to €1.4bn as P&C Combined Ratio Hits 83.2%

Hannover Re H1 2026: Net Income Up 7% as P&C Combined Ratio Improves to 83.2%

Hannover Re reported first-half 2026 group net income of €1.4bn, up 7% from €1.3bn in the same period a year earlier, as operating profit climbed almost 10% to €1.9bn.

The property and casualty (P&C) underwriting result improved sharply: the combined ratio came in at 83.2%, against 88.4% a year earlier and better than the full-year target of under 87%. Large losses were €784.7m, down from €976.1m and below the €1.024bn half-year budget. P&C net reinsurance service result rose to €1.3bn from €975.1m.

Group reinsurance revenue fell 3.1% to €12.9bn, though the company says it would have grown 0.7% at constant exchange rates. In life and health (L&H), gross revenue rose 9.1% to €4.1bn, while the investment result increased to €1.3bn from €1.0bn, an annualised return of 3.7%.

Management reaffirmed 2026 guidance of at least €2.7bn net income, a P&C combined ratio below 87%, roughly €925m L&H net reinsurance service result and around 3.5% return on investment, provided large losses do not significantly exceed €2.3bn.

Inside Hannover Re's H1: Renewal Pricing Pressure, Reserve Builds and L&H Divergence

P&C Profit Rises Even as Revenue Declines

The improvement in P&C did not come from top-line growth. Gross P&C revenue fell 8% to €8.8bn, a decline of 3.9% adjusted for currency. The earnings lift instead came from lower catastrophe and large-loss costs and a higher underwriting service result—Hannover Re's underwriting book became more profitable even while smaller in reported euro terms.

Renewal Pricing Is Softening, but Volume Is Growing

At the June and July renewals, the portion of the book renewed grew 12.3% to €4.24bn, but prices on that business fell 4.5% on a risk-adjusted basis. That pricing decline helps explain why P&C net new business CSM fell 13.3% to €1.7bn, though exchange rates also played a role. The company says rates remain adequate, suggesting it is accepting lower marginal pricing while expanding selected client relationships.

Reserve Strengthening and the Iran Provision

Hannover Re added around €200m for potential impacts of the war in Iran and reserved €75m initially for the June earthquake in Venezuela. Even with those amounts, half-year large losses were below budget. The company also said it strengthened loss reserves, a conservative move that can reduce later earnings volatility but also means current profits are not simply a function of easy loss experience.

Future Profit and Investment Income Are Carrying the Guidance

Group net contractual service margin rose 11.4% to €8.8bn, and the investment result improved to €1.3bn. Those two items matter: the CSM represents unearned future profit in the business written, while the 3.7% annualised return on investment is above the roughly 3.5% full-year target. They give Hannover Re two buffers—future underwriting profit and current asset income—against the softening renewal prices in P&C.

Life and Health: Steady CSM, Weaker Operating Result

The L&H segment grew gross revenue and generated higher net new CSM of €384.8m, but its operating result fell 13.1% to €408.2m. The article does not break down the cause, so the divergence should be read as a sign that top-line growth did not fully translate into segment earnings in the half-year.

What Hannover Re's H1 2026 Figures Signal for Cedents, Investors and Rivals

Hannover Re's H1 disclosure gives counterparties and investors several concrete markers for the rest of 2026:

• Cedents renewing North American catastrophe, Australia/New Zealand or credit and surety business should note that June/July renewed volume grew 12.3% to €4.24bn while risk-adjusted price fell 4.5%—capacity is present, but Hannover Re maintains rates remain adequate.
• Investors following the full-year guidance should track large-loss spend against the €2.3bn assumption: H1 came in at €784.7m, but the €200m Iran war provision and €75m Venezuela earthquake reserve are early and may develop.
• P&C competitors should read the 13.3% decline in net new business CSM to €1.7bn as evidence that renewal price decreases are beginning to reduce margins embedded in new business, even as Hannover Re grows volume.
• Life and health cedents can see continued demand: L&H gross revenue rose 9.1% to €4.1bn, but the segment's operating result fell 13.1% to €408.2m, so top-line appetite did not translate into stronger operating earnings.
• The 3.7% annualised return on investment already exceeds the full-year target around 3.5%, meaning 2026 guidance may be more sensitive to underwriting losses than investment income.